Abiopharma

🔍 Podlesak Dennis (Executive)

Company: Syndax Pharmaceuticals Inc (SNDX)

Reported stock transactions:

• Acquired 19,200 shares of Common Stock at $7.20 per share (directly)
  Date: 2025-08-14 | Code: M
• Sold 19,200 shares of Common Stock at $14.19 per share (directly)
  Date: 2025-08-14 | Code: S
• Acquired 19,200 shares of Common Stock at $7.20 per share (directly)
  Date: 2025-08-15 | Code: M
• Sold 19,200 shares of Common Stock at $15.54 per share (directly)
  Date: 2025-08-15 | Code: S
• Acquired 19,200 shares of Common Stock at $7.20 per share (directly)
  Date: 2025-08-18 | Code: M
• Sold 19,200 shares of Common Stock at $15.84 per share (directly)
  Date: 2025-08-18 | Code: S